142 related articles for article (PubMed ID: 9311587)
1. ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.
Casson AG; Wilson SM; McCart JA; O'Malley FP; Ozcelik H; Tsao MS; Chambers AF
Int J Cancer; 1997 Sep; 72(5):739-45. PubMed ID: 9311587
[TBL] [Abstract][Full Text] [Related]
2. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
[TBL] [Abstract][Full Text] [Related]
3. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus.
Galiana C; Lozano JC; Bancel B; Nakazawa H; Yamasaki H
Mol Carcinog; 1995 Dec; 14(4):286-93. PubMed ID: 8519418
[TBL] [Abstract][Full Text] [Related]
4. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
6. A point mutation of c-Ki-ras gene was found in human esophageal carcinoma cell lines but not in primary esophageal carcinomas.
Shiga C; Shiga K; Sasano H; Mori S
Biochem Biophys Res Commun; 1992 Aug; 187(1):515-21. PubMed ID: 1520342
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.
Gaur D; Arora S; Mathur M; Nath N; Chattopadhaya TK; Ralhan R
Clin Cancer Res; 1997 Nov; 3(11):2129-36. PubMed ID: 9815606
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.
Lam KY; Tsao SW; Zhang D; Law S; He D; Ma L; Wong J
Int J Cancer; 1997 Apr; 74(2):212-9. PubMed ID: 9133458
[TBL] [Abstract][Full Text] [Related]
10. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas.
Kim K; Cai J; Shuja S; Kuo T; Murnane MJ
Int J Cancer; 1998 Aug; 79(4):324-33. PubMed ID: 9699522
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
Tuck AB; Wilson SM; Khokha R; Chambers AF
J Natl Cancer Inst; 1991 Apr; 83(7):485-91. PubMed ID: 1848638
[TBL] [Abstract][Full Text] [Related]
12. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
13. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
[TBL] [Abstract][Full Text] [Related]
14. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
[TBL] [Abstract][Full Text] [Related]
16. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
17. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
18. [Overexpression of p53 protein in human spontaneous esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)].
Guo YJ
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):241-4. PubMed ID: 1396069
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-K-ras mutations in human gastrointestinal tumors.
Arber N; Shapira I; Ratan J; Stern B; Hibshoosh H; Moshkowitz M; Gammon M; Fabian I; Halpern Z
Gastroenterology; 2000 Jun; 118(6):1045-50. PubMed ID: 10833479
[TBL] [Abstract][Full Text] [Related]
20. Oncogene activation in esophageal cancer.
Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
J Thorac Cardiovasc Surg; 1991 Nov; 102(5):707-9. PubMed ID: 1943188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
